Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
10.58
-0.98 (-8.48%)
Mar 31, 2025, 3:46 PM EDT - Market open
Sionna Therapeutics Employees
Sionna Therapeutics had 41 employees as of December 31, 2024. The number of employees increased by 13 or 46.43% compared to the previous year.
Employees
41
Change (1Y)
13
Growth (1Y)
46.43%
Revenue / Employee
n/a
Profits / Employee
-$1,504,585
Market Cap
466.84M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41 | 13 | 46.43% |
| Dec 31, 2023 | 28 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SION News
- 11 days ago - Sionna Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 5 weeks ago - Sionna Therapeutics to Present at the 45th Annual TD Cowen Health Care Conference - GlobeNewsWire
- 6 weeks ago - Sionna Therapeutics Announces Closing of $219.2 million Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 7 weeks ago - U.S. IPO Weekly Recap: Cement And Cystic Fibrosis Drugs Lead A 6 IPO Week - Seeking Alpha
- 7 weeks ago - Sionna Therapeutics Prices Upsized Initial Public Offering - GlobeNewsWire
- 2 months ago - U.S. IPO Weekly Recap: Active January Closes Out With Several Sizable IPOs - Seeking Alpha
- 2 months ago - Sionna Therapeutics Seeks $100 Million in IPO For Cystic Fibrosis Treatments - Seeking Alpha
- 2 months ago - Cystic fibrosis biotech Sionna Therapeutics files for a $100 million IPO - Renaissance Capital